Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown on the page, replacing the previous v3.4.0. This is a minor site update and does not modify any study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-02-06T09:15:04.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    UI text updates: Show glossary and Hide glossary options have been added, QC-related labels updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and the 'No FEAR Act Data' wording adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T17:39:02.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added to the page. The previous Revision: v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-15T10:45:21.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Locations section updated to group sites under a centralized 'Locations' heading and to include Kentucky. The former 'Kentucky Locations' subsection has been removed.
    Difference
    0.2%
    Check dated 2025-12-17T20:25:56.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The Publications section now states that items are automatically filled from PubMed and may not be about the study. Revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:57:02.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.